Medtronic, Inc. (MDT)
$42.48
-0.51 (-1.19%)
| CAPS Rating |
|
|---|---|
| Open | $42.67 |
| Previous Close | $42.99 |
| Daily Range | $42.03 - $42.77 |
| 52-Week Range | $24.06 - $40.46 |
| Market Cap | $47.02B |
| P/E Ratio | 23.71 |
| Dividend (Yield) | 0.82 (1.90%) |
| Volume | 4,515,727 |
| Average Daily Volume | 6,511,000 |
How do you think MDT will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MDT Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MDT News and Commentary
- The Comeback Kids: The Interviews – SmartMoney
- 4-Star Stocks Poised to Pop: Cytori Therapeutics – The Motley Fool
- Tuesday's Biggest Stock Stars – The Motley Fool
- MARKET SNAPSHOT: U.S. Stocks End Slightly Lower After Fed Minutes – SmartMoney
- 52-Week Highs! What's Going On? – The Motley Fool
- MARKET SNAPSHOT: Stocks Strengthen After Fed Minutes – SmartMoney
- MARKET SNAPSHOT: Stocks Resume Slide; Losses Cut After Fed Minutes – SmartMoney
- MARKET SNAPSHOT: Stocks Resume Slide; Fed Minutes Do Little To Help – SmartMoney
- MARKET SNAPSHOT: Stocks Resume Slide In Afternoon Trade – SmartMoney
- MARKET SNAPSHOT: U.S. Stocks Rattled By Fresh Financial Worries – SmartMoney
- Speaking of "Homework", your assignment: Earnings Release research – Blog at The Motley Fool
- MARKET SNAPSHOT: U.S. Stocks Rattled By Fresh Financial Worries – SmartMoney
- MARKET SNAPSHOT: U.S. Stocks Rattled By Fresh Financial Worries – SmartMoney
- UPDATE: Medtronic 2Q Profit Soars 59%; EPS Guidance Raised – SmartMoney
- Medtronic 2Q Profit Soars 59%, Company Boosts EPS Forecast – SmartMoney
- UPDATE 1-Medtronic quarterly earnings top estimates – Reuters
- 7 Reasons Not to Worry This Week – The Motley Fool
- US EQUITIES WEEK AHEAD: H-P Results, Home Sales Data, Holiday – SmartMoney
- US Senate Bill Includes Lower $2 Billion Medical Device Tax – SmartMoney
- BUY OR SELL-Is Medtronic immune to device sector turmoil? – Reuters


RSS Headlines
Fool UK